Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced on Apr, 30 2026 that there have been no material developments in the bankruptcy liquidation of its 55%-owned subsidiary, Tianjin Shin Poong Pharmaceutical Co., Ltd., since the previous update issued on Mar, 30 2026.

The company stated it will continue to monitor the court-supervised process, keep open communication with the administrator, and release further monthly updates as required under Rule 704(23) of the Listing Manual.

Tianjin Pharmaceutical Da Ren Tang Group also advised shareholders and potential investors to exercise caution when trading its shares.